Benvitimod (Tapinarof) CAS 79338-84-4: Pharmaceutical Intermediate Manufacturer and Supplier for Psoriasis Treatment

Discover Benvitimod (Tapinarof) CAS 79338-84-4, a key pharmaceutical intermediate for developing advanced treatments for psoriasis and eczema. As a leading manufacturer and supplier in China, we offer high-purity Benvitimod to support your R&D and production needs.

Get a Quote & Sample

Advantages of Sourcing Benvitimod

Superior Quality Assurance

Our Benvitimod (CAS 79338-84-4) meets stringent quality standards, essential for pharmaceutical intermediates. We offer detailed product specifications to support your regulatory compliance needs.

Reliable Supply Chain Management

As a leading manufacturer, we guarantee a stable and consistent supply of Benvitimod to meet your production demands. Benefit from our efficient inventory management and timely delivery.

Competitive Pricing from China

Leverage our position as a primary supplier in China to secure Benvitimod at competitive prices. We provide cost-effective solutions for your pharmaceutical intermediate requirements.

Benvitimod Application Areas

Psoriasis Treatment Development

Benvitimod is critical for synthesizing APIs that treat psoriasis by modulating immune responses and reducing inflammation. Inquire about bulk purchase options.

Eczema Therapy Research

The anti-inflammatory properties of Benvitimod make it a valuable intermediate for developing new treatments for eczema and other inflammatory skin conditions.

Pharmaceutical Intermediate Synthesis

As a versatile pharmaceutical intermediate, Benvitimod (CAS 79338-84-4) supports the creation of novel drug candidates in various therapeutic areas.

API Manufacturing & R&D

We supply Benvitimod to R&D departments and API manufacturers globally, ensuring they have access to high-quality materials for their innovative processes.